Trends in Pharmacological Sciences
ReviewRole of rho kinase in the functional and dysfunctional tonic smooth muscles
Section snippets
Myogenic properties of tonic smooth muscles
Smooth muscles can be broadly classified according to the contractile patterns: phasic and tonic. Phasic smooth muscles contract transiently in response to neural stimulation and neurohumoral substances such as angiotensins and prostanoids. By contrast, tonic smooth muscles develop and sustain myogenic basal tone in the absence of an external stimulation. The term ‘myogenic’ implies that the stimulus for tone development and maintenance originates in the muscle itself, and its response is
Role of the Ca2+/calmodulin pathway in the smooth muscle motor response
The motor response in SMCs is controlled by the sliding of myosin and actin filaments over each other. This process requires chemical energy, which is provided by the hydrolysis of ATP (Figure 1). Myosin utilizes ATP for molecular conformational changes in its own structure to facilitate its attachment and interaction with actin filaments, leading to the formation of cross-bridges. Myosin attachment occurs through protruding globular heads in the myosin filaments that interact with actin
The RhoA/ROCK pathway
RhoA belongs to a family of small GTPases that include RhoA, RhoB and RhoC isoforms, of which RhoA is the best understood because of its important roles in the smooth muscle motility. RhoA might have high-affinity binding to guanosine trisphosphate (GTP) as well as guanosine diphosphate (GDP). However, the active form of RhoA is bound to GTP located in the cell membrane, whereas the GDP-bound form is inactive and located in the cytoplasm. Switching between the GDP/GTP-bound forms is controlled
Role of PKC vs RhoA/ROCK in the maintenance of basal tone
Both PKC and ROCK have been implicated in the inhibition of MLCP activity via phosphorylation of CPI-17 at threonine-38 (Thr38) residue (pThr38-CPI-17 or simply p-CPI-17). CPI-17 is an endogenous inhibitory protein of the catalytic subunit of MLCP 15, 49, 52, 53, 54. p-CPI-17 is ∼7000-fold more potent than nonphosphorylated CPI-17. Phosphorylation of CPI-17 by ROCK has also been suggested by in vivo studies 15, 55, 56. In these studies, increase in p-CPI-17 was specifically inhibited by the
Therapeutic potential of RhoA/ROCK inhibitors in GI diseases
Prototypes of tonic tissues, the LES and IAS, play major roles in the pathophysiology of several GI motility disorders. The LES maintains tone in the basal state and relaxes during swallowing to allow passage of food. Similarly, the IAS maintains spontaneous tone and relaxes to allow passage of processed food in response to the rectoanal inhibitory reflex that is initiated by rectal distension caused by the stool. Significant changes in the basal tone of the IAS and LES have been directly
Therapeutic potential of RhoA/ROCK inhibitors in cardiovascular diseases
As in GI smooth muscles, the contractile state of vascular SMCs (VSMCs) depends on the levels of p-MLC20 determined by the balance between the activities of Ca2+/CaM/MLCK-dependent (plus Ca2+-independent) and the MLCP pathways 19, 38, 43. Several neurohumoral agonists (e.g. Ang II and prostanoids) are known to modulate these pathways via GPCRs that lead not only to increases in the [Ca2+]i but also stimulate RhoA/ROCK. Thus, as outlined above, the inhibition of MLCP via p-MYPT1 and/or p-CPI-17
Therapeutic potential of RhoA/ROCK silencing with small interfering RNA (siRNA)
The main advantage of a siRNA approach over conventional inhibitors is that the conventional inhibitors such as Y27632 do not exhibit specificity for the ROCK isoforms. In addition, siRNAs are potentially ∼1000-fold more potent than the conventional ROCK inhibitors 13, 41, 94, 95, 96, 97, 98, 99, 100.
Because the pathophysiology of many diseases is based on the overexpression of certain genes, and intense research on gene function has allowed the identification of many putative target genes,
Concluding remarks
Basal tone in the smooth muscles of the GI sphincters (typified by the LES and IAS) and those of certain blood vessels of the cardiovascular system provide true representations of the sustained contraction in the absence of any exogenous stimulus or agonist. The basal tone in such smooth muscles is primarily myogenic. However, the molecular mechanisms underlying the myogenic control in relation to the external triggers (perhaps produced within the cells) and other modulatory neurohumoral
Acknowledgments
This work was supported by the National Institutes of Diabetes and Digestive and Kidney Diseases Grant DK-35385, and an institutional grant from Thomas Jefferson University.
References (112)
Rho kinase as a novel molecular therapeutic target for hypertensive internal anal sphincter
Gastroenterology
(2006)Rho-kinase contributes to sustained RhoA activation through phosphorylation of p190A RhoGAP
J. Biol. Chem.
(2009)Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation
J. Biol. Chem.
(1997)Evidence for the role of angiotensin II biosynthesis in the rat internal anal sphincter tone
Gastroenterology
(2004)Bioengineered internal anal sphincter derived from isolated human internal anal sphincter smooth muscle cells
Gastroenterology
(2009)Rho kinase and hypertension
Biochim. Biophys. Acta
(2010)Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases
Drug Discov. Today
(2010)Characterization of RhoA-binding kinase ROKα implication of the plecktsrin homology domain in ROKα function using region-specific antibodies
J. Biol. Chem.
(2002)Phosphorylation of CPI-17, and inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase
FEBS Lett.
(2000)Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility
J. Biol. Chem.
(2000)
Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase)
J. Biol. Chem.
Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CPI17) in smooth muscle: its specific localization in smooth muscle
FEBS Lett.
Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors
J. Biol. Chem.
Paticipation of Rho-associated kinase in electrical stimulated and acetylcholine-induced contraction of feline esophageal smooth muscle
Eur. J. Pharmacol.
Surgical implantation of a bioengineered internal anal sphincter
J. Ped. Surg.
H-ras inhibits RhoA/ROCK leading to a decrease in the basal tone in the internal anal sphincter
Gastroenterology
Activation of c-K-ras mutations in human gastrointestinal tumors
Gastroenterology
A prospective evaluation of anorectal function after total mesorectal excision in patients with a rectal carcinoma
Surgery
Comparison of angiotensin II (Ang II) effects in the internal anal sphincter (IAS) and lower esophageal sphincter smooth muscles
Life Sci.
Loss of Lsc/p115 protein leads to neuronal hypoplasia in the esophagus and an achalasia-like phenotype in mice
Gastroenterology
Identification of potential mechanisms for regulation of p115 RhoGEF through analysis of endogenous and mutant forms of the exchange factor
J. Biol. Chem.
RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals
Cell
Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway
Cell
Smooth muscle tone
Physiol. Rev.
Signal-transduction pathways that regulate smooth muscle function I. Signal transduction in phasic (esophageal) and tonic (gastroesophageal sphincter) smooth muscles
Am. J. Physiol. Gastrointest. Liver Physiol.
Phasic and tonic contraction processes in the gastrointestinal tract
Dig. Dis. Sci.
Regulation of basal tone, relaxation, and contraction of the lower esophageal sphincter. Relevance to drug discovery for esophageal disorders
Br. J. Pharmacol.
Genesis of anal canal pressures in the opossum
Am. J. Physiol. Gastrointest. Liver Physiol.
Physiology of normal esophageal motility
J. Clin. Gastroenterol.
The internal anal sphincter: regulation of smooth muscle tone and relaxation
Neurogastroenterol. Motil.
The myogenic response
Myogenic response gradient in an arteriolar network
Am. J. Physiol. Heart Circ. Physiol.
siRNA knock down of casein kinase 2 increases force and cross-bridge cycling rates in vascular smooth muscle
Am. J. Physiol. Cell Physiol.
Signaling for contraction and relaxation in smooth muscle of the gut
Annu. Rev. Physiol.
RhoA/ROCK-kinase: pathophysiologic and therapeutic implications in gastrointestinal smooth muscle tone and relaxation
Gastroenterology
Protein kinase network in the regulation of phosphorylation and dephosphorylation of smooth muscle myosin light chain
Mol. Cell Biochem.
Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm
Arterioscler. Thromb. Vasc. Biol.
Rho GTPases: functions and association with cancer
Clin. Exp. Metastasis
Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells
Am. J. Physiol. Cell Physiol.
Regulation of smooth muscle contraction by small GTPases
Physiology
Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+ sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697
Biochem. J.
The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction
Curr. Hypertens. Rep.
Receptor-independent activation of Rho-kinase-mediated calcium sensitisation in smooth muscle
Br. J. Pharmacol.
Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells
J. Cell Sci.
Autocrine regulation of internal anal sphincter tone by renin-angiotensin system: comparison with phasic smooth muscle
Am. J. Physiol. Gastrointest. Liver Physiol.
Actions by angiotensin II on esophageal contractility in humans
Gastroenterology
Role of phospholipase A2 (group I secreted) in the genesis of basal tone in the internal anal sphincter smooth muscle
Am. J. Physiol. Gastrointest. Liver Physiol.
COX-1 vs. COX-2 as a determinant of the basal tone in the internal anal sphincter
Am. J. Physiol. Gastrointest. Liver Physiol.
Group I secreted PLA2 (sPLA2) and arachidonic acid metabolites in the maintenance of cat LES tone
Am. J. Physiol. Gastrointest. Liver Physiol.
Group I secreted PLA2 in the maintenance of human lower esophageal sphincter tone
Gastroenterology
Cited by (59)
Molecular mechanisms underlying hyperoxia-induced lung fibrosis
2022, Pediatrics and NeonatologyROCK inhibitors 4: Structure-activity relationship studies of 7-azaindole-based rho kinase (ROCK) inhibitors
2021, Bioorganic and Medicinal Chemistry LettersPharmacology and perspectives in erectile dysfunction in man
2020, Pharmacology and TherapeuticsCitation Excerpt :The activation process involves the dissociation of RhoA that translocates from the cytosol to the membrane, enabling the downstream activation of various effectors such as Rho kinase. Phosphorylation of the regulatory subunit of MLC phosphatase by Rho kinase causes inhibition of phosphatase activity, which enhances the contractile response (de Godoy & Rattan, 2011). An in vitro study showed the presence of the expression of Rho-kinase in primary cultures of human cavernosal smooth muscle cells (Rees et al., 2002).
Quantitative in situ proximity ligation assays examining protein interactions and phosphorylation during smooth muscle contractions
2019, Analytical BiochemistryCitation Excerpt :These actin filament modifications and remodeling are thought to facilitate the polymerization of cortical cytoskeletal actin filaments to increase the stability of focal adhesions in the membrane, allowing for the force generated by actin filaments attached to the cytoplasmic domains of β1integrin by talin to be transmitted to the connective tissue of the extracellular matrix [22–25]. Numerous studies, including our own, have utilized SDS-PAGE and western blotting techniques to measure changes in phosphorylation of these regulatory proteins, to demonstrate the importance of these myofilament sensitizing mechanisms for smooth muscle contractions [14,15,26–29]. Co-immunoprecipitation (Co-IP) approaches have also revealed a number of interactions between contractile proteins and focal adhesions in smooth muscles [30–34].